AzTrials
AzTrials

Ostomy - Ileostomy or ColostomyNCT02176954

The Influence of Adhesive Wafer Design on Fit to the Body

A study testing Test A, Test B and Comparator in people with Ostomy - Ileostomy or Colostomy, run by Coloplast A/S at 10 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the influence of the adhesive wafer design on the products ability to fit to the body.. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Ostomy - Ileostomy or Colostomy
What is being tested?
Test A, Test B and Comparator
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
10 sitesin 2 countries
Study dates
Jul 2014to Mar 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • To participate in the study, it is mandatory that the subject fulfill all inclusions criteria:
  • Have given written informed consent and signed letter of Authority
  • Be at least 18 years of age and have full legal capacity
  • Have had their ileostomy or colostomy for at least 3 months
  • Have a stoma with a diameter between 15 and 43 mm
  • Be able to handle the product themselves
Show all 14Show fewer
  • Be able to use a custom cut product
  • Normally experience faeces under the adhesive wafer at least 3 times during 2 weeks
  • Currently using a 1-piece flat product or a 1-piece soft convex product
  • Be willing to test products with open bag size maxi
  • Be willing to test Moderma Flex or Confidence® Natural, Drainable and the two test products A and B
  • Be willing to use minimum 1 test product every second day, i.e. maximum 48 hours wear time per product
  • Be suitable for participating in the investigation
  • Be willing to take/have taken pictures of the stoma before, during and after application of product

Who cannot join

  • Subjects complying with the following criteria must be excluded from participation in the clinical investigation:
  • Are currently receiving or have within the past 2 months received radio-and/or chemotherapy
  • Are currently receiving or have within the past month received topical steroid treatment in the peri-stomal skin area or systemic steroid (tablet/injection) treatment
  • Are pregnant or breastfeeding
  • Are participating in other interventional clinical investigations or have previously participated in this investigation
  • Use irrigation during the investigation (flush the intestines with water)
Show all 9Show fewer
  • Are currently suffering from peri-stomal skin problems i.e. bleeding and/or broken skin (assessed by the study nurse)
  • Have a loop stoma
  • Have known hypersensitivity towards any of the test products

Trial locations and contacts

10 sites in 2 countries.

10 sites in 2 countries

United Kingdom9 sites
  • Synexus Thames Valley

    Berkshire, RG2 0TG

  • Synexus Midlands

    Birmingham, B15 2SQ

  • Synexus Wales

    Cardiff, CF14 5GJ

  • Synexus Scotland

    Glasgow, G20 0SP

  • Cheltenham General Hospital

    Gloucestershire, G1537AN

  • Synesxus Lancashire

    Lancashire, PR7 7NA

  • Synexus Merseyside

    Liverpool, L22 0LG

  • Synexus Manchester

    Manchester, M15 6SX

  • Synexus North East

    Northumberland, NE46 1QJ

Other trials in United Kingdom

Netherlands1 site
  • QPS Netherlands

    Groningen, 9713

Other trials in Netherlands

About this study

The aim of this study is to investigate the influence of the adhesive wafer design on the products ability to fit to the body..

Being tested
Test A, Test B, Comparator

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Test ADevice

    Test A is a new 1-piece ostomy appliance developed by Coloplast A/S

  • Test BDevice

    Test B is a new 1-piece ostomy appliance developed by Coloplast A/S

  • ComparatorDevice

    Two comparators will be used: Moderma Flex (Hollister) or Confidence Natural drainable (Salts).These product are commercially available.

    Subjects will be randomized into one of twelwe arms. Data will be analyzed by pooling the two comparators, Moderma Flex and Confidence Natural, Drainable, why six arms are displayed.

Study groups in NCT02176954
Study groupRoleWhat they receive
Test A, Test B, ComparatorExperimentalThe subjects first test Coloplast Test A followed by Coloplast Test B and finally Comparator.
Receives: Device: Test A; Device: Test B; Device: Comparator
Test A, Comparator, Test BExperimentalThe subjects first test Coloplast Test A followed by Comparator and finally Coloplast Test B.
Receives: Device: Test A; Device: Test B; Device: Comparator
Test B, Test A, ComparatorExperimentalThe subjects first test Coloplast Test B followed by Coloplast Test A and finally Comparator.
Receives: Device: Test A; Device: Test B; Device: Comparator
Test B, Comparator, Test AExperimentalThe subjects first test Coloplast Test B followed by Comparator and finally Coloplast Test B.
Receives: Device: Test A; Device: Test B; Device: Comparator
Comparator, Test A, Test BExperimentalThe subjects first test Comparator followed by Coloplast Test A and then Coloplast Test B
Receives: Device: Test A; Device: Test B; Device: Comparator
Comparator, Test B, Test AExperimentalThe subjects first test Comparator followed by Coloplast Test B and then Coloplast Test A.
Receives: Device: Test A; Device: Test B; Device: Comparator

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fit to body

    Subjects will evaluate the fit to body for each product by answering the question "How was the base plates ability to fit the body contours in the area around the stoma?"

    The question is answered with a 5-point scale ranging from Very Poor - Very Good (1-5), where the very poor (1) is the worst possible score and very good (5) is the best possible score.

    Measured: 14 +/- 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionFeb 2015
  4. Study completionMar 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02176954
Sponsor's protocol ID
CP247
Status last verified
Mar 2015
First submitted
26 Jun 2014
Last updated
23 Mar 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Test A, Test B and Comparator in people with Ostomy - Ileostomy or Colostomy, run by Coloplast A/S at 10 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 10 sites in United Kingdom, Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fit to body (time frame: 14 +/- 2 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in